Drug profile · INN
disopyramide
RYTHMODAN (UK)
disopyramide (RYTHMODAN (UK)) is a sodium channel alpha subunit blocker. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — disopyramide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
disopyramide (RYTHMODAN (UK)) is a sodium channel alpha subunit blocker. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN disopyramide
Brand RYTHMODAN (UK)
Mechanism Sodium channel alpha subunit blocker
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Sodium channel alpha subunit blocker
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is disopyramide?
disopyramide (RYTHMODAN (UK)) is a sodium channel alpha subunit blocker. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for disopyramide?
RYTHMODAN (UK) is a marketed brand name for disopyramide. Check FDA Drugs@FDA for the current US label holder and prescribing information.